Who is sponsoring NCT05592522?

NCT05592522 is sponsored by Al Mashfa Medical Center.

What drugs are being tested in NCT05592522?

Interventions in NCT05592522: External oblique intercostal block, Oblique subcostal TAP block, Posterior Rectus sheath block.

What condition does NCT05592522 study?

NCT05592522 studies Bariatric Surgery Candidate, Pain, Postoperative, Narcotic Use, Analgesia.

Is NCT05592522 still recruiting?

NCT05592522 is currently completed. Last updated 28 February 2023.

Last reviewed 2023-02-28 · How we verify

NCT05592522

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of External Oblique Intercostal Block in Laparoscopic Bariatric Surgery

Completed NA Last updated 28 February 2023

What this trial tests

NA trial testing External oblique intercostal block in Bariatric Surgery Candidate in 73 participants. Completed in 20 February 2023.

Timeline

26 October 2022

Primary endpoint
20 February 2023

20 February 2023

Quick facts

Lead sponsor	Al Mashfa Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	73
Start date	26 October 2022
Primary completion	20 February 2023
Estimated completion	20 February 2023
Sites	1 location across Saudi Arabia

Drugs / interventions tested

External oblique intercostal block
Oblique subcostal TAP block
Posterior Rectus sheath block

Conditions studied

Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Pain, Postoperative — all drugs for Pain, Postoperative →
Narcotic Use — all drugs for Narcotic Use →
Analgesia — all drugs for Analgesia →

Sponsor

Al Mashfa Medical Center

Who can join

Adults 18 to 65, any sex, with Bariatric Surgery Candidate or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic bariatric procedures nowadays are employed under ERAS protocol as an ambulatory surgery. Pain after laparoscopic procedures arises significantly from port site incisions in the anterior abdominal wall, and shoulder pain (referred from visceral pain). Narcotic medications are utilized to manage postoperative pain, but its disadvantages include, increased post-operative nausea and vomiting (PONV), ileus, sedation and delayed hospital discharge. Oblique subcostal transversus abdominis plane block (OSTAP) had been studied before and found to be effective in reducing post-operative morphine usage and produce good analgesia for about 24hours postoperatively. The ultrasound-guided external oblique intercostal (EOI) block is a new technique which proved to produce unilateral analgesia at thoracic dermatomes supplying the anterior and lateral aspects of the upper abdomen. The aim of this study was to test the hypothesis that US-guided EOI blocks can produce more reduction in opioid usage during the first 24 h after of laparoscopic bariatric surgeries when compared to oblique subcostal TAP (OSTAP) block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bariatric Surgery Candidate

Currently open trials in the same condition.

NCT07525232 — Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients · NA · recruiting
NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
NCT05966727 — Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients · NA · recruiting
NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting

Other Al Mashfa Medical Center trials

Trials by the same sponsor.

NCT04285255 — Quality of Recovery Following Opioids Free Anaesthesia in Laparoscopic Sleeve Gastrectomy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05592522 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al Mashfa Medical Center
Last refreshed: 28 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05592522.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing